Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

85.1K
Overview
85.1K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

2.2K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.2K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
What is the Immune System?01:38

What is the Immune System?

137.6K
Overview
137.6K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

7.7K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.7K
Humoral Immune Responses01:36

Humoral Immune Responses

84.7K
Overview
84.7K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Human monoclonal IgG selection of Plasmodium falciparum for the expression of placental malaria-specific variant surface antigens.

Parasite immunology·2009
Same author

Distinct expression pattern of IFN-alpha and TNF-alpha in juvenile idiopathic arthritis synovial tissue.

Rheumatology (Oxford, England)·2006
Same author

Cytokine-driven proliferation and differentiation of human naïve, central memory and effector memory CD4+ T cells.

Pathologie-biologie·2003
Same author

Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells.

The Journal of experimental medicine·2001
Same author

BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction.

The Journal of experimental medicine·2001
Same author

Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells.

European journal of immunology·2001

関連する実験動画

Updated: Mar 1, 2026

Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors
05:58

Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors

Published on: August 16, 2024

3.9K

免疫介入のための戦略を特定する.

A Lanzavecchia1

  • 1Basel Institute for Immunology, Switzerland.

Science (New York, N.Y.)
|May 14, 1993
PubMed
まとめ

T細胞の認識と活性化経路を理解することで,免疫システムへの介入が可能になります. この知識は,ワクチンの開発,抗腫瘍反応,自己免疫疾患と移植拒絶の管理に役立ちます.

科学分野:

  • 免疫学 免疫学とは
  • 分子生物学は分子生物学である.
  • ワクチン学 ワクチン学

背景:

  • T細胞の抗原認識の分子機構は,ますます理解されています.
  • T細胞の活性化と特異化を調節する経路が定義されています.

研究 の 目的:

  • 治療戦略のためのT細胞生物学における最近の進歩を活用する.
  • ワクチン開発,がん免疫療法,移植/自己免疫疾患管理のための介入を検討する.

主な方法:

  • T細胞の抗原認識の分子分析.
  • T細胞の活性化と機能的経路の解明.

主要な成果:

  • T細胞が抗原を認識する方法の詳細な理解.
  • T細胞の活性化と特異化を制御する定義された経路.

結論:

  • T細胞経路の知識は,標的型免疫システム介入を可能にします.
  • 戦略は,ワクチン,腫瘍免疫,移植耐性,および自己免疫疾患の制御のために設計することができます.

さらに関連する動画

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction
08:02

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction

Published on: January 22, 2020

6.0K
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.9K

関連する実験動画

Last Updated: Mar 1, 2026

Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors
05:58

Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors

Published on: August 16, 2024

3.9K
In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction
08:02

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction

Published on: January 22, 2020

6.0K
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.9K